Breaking News

Caprion-HistoGeneX Rebrands as CellCarta

Recently expanded its scientific capabilities and geographic presence with the acquisitions of Clinical Logistics Inc. and Mosaic Laboratories.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Caprion-HistoGeneX, a Montreal-based global provider of specialized precision medicine lab services, has rebranded as CellCarta. The company’s mission is mapping the content and function of human cells to enable and accelerate the evolution of personalized precision medicine.   The new name stems from the 2019 combination of CRO Caprion Biosciences, which specializes in immunology and proteomics services, and HistoGeneX, a provider of histopathology and genomics services based in Antwerp...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters